Amgen Inc

AMGNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 17/3039% above fair value

$465.45−0.56 (-0.12%)

Close on Nov 2, 2026Market cap $251.64BP/E 28.9Yield 2.08%

Amgen KANJINTI (trastuzumab-anns by Year

Name: Amgen KANJINTI (trastuzumab-anns by Year (AMGN)
Creator: Amgen

KANJINTI (trastuzumab-anns — Herceptin Biosimilar, legacy standalone disclosure) — Worldwide product sales ($M) ($M)

Quarterly Annual

Amgen KANJINTI (trastuzumab-anns: $159M in FY2023, down 49.7% from a year earlier. No newer figure appears in the documents we track.

Latest, FY2023

159

Period ended Dec 31, 2023

Change on a year earlier

-49.7%

316 in FY2022

History

6 years

Since FY2018

Sources

Documents cited below

Where the FY2023 figure comes from

“|| KANJINTI ® | 109 | 50 | 159 | 316 | (50%)”

Source: Form 8-K (amgn-20231231earningsrelea.htm, filed 2024-02-06) ↗

Reported in Form 10-Q / 10-K Segment & Revenue Disaggregation Note & Form 8-K Product Sales Detail.

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

Period	Ended	KANJINTI (trastuzumab-anns — Herceptin Biosimilar, legacy standalone disclosure) — Worldwide product sales ($M) ($M)	Year on year	Source
FY2023	Dec 31, 2023	159	-49.7%	Form 8-K (amgn-20231231earningsrelea.htm, filed 2024-02-06) ↗
FY2022	Dec 31, 2022	316	-44.8%	Form 8-K (amgn-20221231earningsrelea.htm, filed 2023-01-31) ↗
FY2021	Dec 31, 2021	572	+0.9%	Form 8-K (amgenq42021earningsrelease.htm, filed 2022-02-07) ↗
FY2020	Dec 31, 2020	567	+150.9%	Form 8-K (amgn-20201231xq4ex991.htm, filed 2021-02-02) ↗
FY2019	Dec 31, 2019	226	+413.6%	Form 8-K (amgn-20191231xq4ex991.htm, filed 2020-01-30) ↗
FY2018	Dec 31, 2018	44	–	Form 8-K (amgn-20191231xq4ex991.htm, filed 2020-01-30) ↗

Breakdown

What makes up KANJINTI (trastuzumab-anns

Cite this data

StockData. (2026). Amgen KANJINTI (trastuzumab-anns ($M), annual FY2018–FY2023 [Data set]. Compiled from Amgen SEC filings and investor materials. https://stockdatahq.com/stocks/amgn/kpis/prod-kanjinti-ww

See every metric in the Amgen KPI table. Data updated Oct 28, 2026.